Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Alzheimer's disease, Parkinson's disease, and Huntington's disease are common
neurodegenerative diseases. Tau is a microtubule-associated protein, and aggregated tau
resulting from hyperphosphorylation is a pathological feature of a group of neurodegenerative
diseases known as tauopathies. The 18F-T807 (AV1451) molecular probe is a novel molecularly
targeted imaging agent that exhibits high affinity and good selectivity for tau.
Phase:
Early Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University